Recent Headlines
Within Biotechnology
New National Study Reports $1.3 Billion Invested in Colorado Bioscience Companies 2002-Q2 2008, Ranking Colorado 11th in U.S. for Bioscience Venture Capital Investments
Gov. Bill Ritter, the Colorado BioScience Association and Colorado Office of Economic Development released the Colorado Bioscience Roadmap 2008 on January 23. Among findings, the new study reports $1.3 billion was invested in Colorado bioscience companies 2002 through Q2 2008, ranking Colorado 11th in the U.S. for bioscience venture capital investments. - January 27, 2009 - Colorado BioScience Association
AnaSpec Introduces New AnaTagTM HiLyte FluorTM 594 & 680 Protein Labeling Kits
AnaSpec has announced the inclusion of two new dyes in its AnaTagTM protein labeling kit collection - HiLyte FluorTM 594 (Ex/Em=593/616 nm) and HiLyte FluorTM 680 (Ex/Em=678/699 nm). Developed by AnaSpec, HiLyte FluorTM dyes are a series of dyes that spans the whole visible spectrum (Figure... - January 25, 2009 - AnaSpec, EGT Group
Nanion Nominated for the German Industry’s Innovation Award
Nanion is again nominated for a prestigious innovation award, due its impressive product portfolio of automated patch clamp systems. More than 350 companies competed in this year’s Innovation Award and Nanion is finalist in the category “Start-Up Companies.” - January 23, 2009 - Nanion Technologies GmbH
FDA Advice for 2009 Published by Lean Compliance Expert and Cerulean Associates
2009 will be a year of transition for the FDA, with new leadership and renewed Congressional scrutiny, resulting in an agency eager to prove its mettle and toughness on the pharmaceutical, biotech and medical device industries it regulates. - January 18, 2009 - Cerulean Associates LLC
AnaSpec Introduces New ClearPointTM beta-Amyloid Peptides
ClearPointTM peptides are AnaSpec’s trademark collection of heavy or stable isotope labeled peptides and amino acids. - January 11, 2009 - AnaSpec, EGT Group
BioPortfolio’s Website Traffic Increases Over 500%
BioPortfolio, the leading careers, news and information resource for the life sciences and pharmaceutical industries, experienced dramatic growth in website traffic in 2008. According to Compete™ Inc., a website that offers competitive website traffic metrics, BioPorfolio’s traffic... - January 10, 2009 - BioPortfolio
AnaSpec’s Published References Pass 700
The number of published papers that cite AnaSpec’s products has passed 700. - January 09, 2009 - AnaSpec, EGT Group
Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting
Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic. According to the investigators at Memorial Sloan-Kettering Cancer... - December 22, 2008 - Hybrid Silica Technologies Inc.
AnaSpec Introduces Line of Fluorescent Probes for Nucleic Acids
AnaSpec carries a variety of premium quality stains, including cell-impermeant and cell-permeant nucleic acid stains. - December 21, 2008 - AnaSpec, EGT Group
University of New Brunswick and AnaSpec Present Poster at ASCB2008
AnaSpec, in collaboration with the U. of New Brunswick and the Natural Sciences and Engineering Research Council of Canada (NSERC), presented a poster entitled, “The Expression and Activity of MMPs during Zebrafish (Danio rerio) Development." - December 20, 2008 - AnaSpec, EGT Group
Ground-Breaking Anti-Amnesic and Neuroprotective Effects of Alzheimer's Compound ANAVEX 1-41 Published in Journal of Neuropsychopharmacology
Anavex Life Sciences Corp. (OTCBB: AVXL), a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, announces that the anti-amnesic and neuroprotective effects of ANAVEX 1-41 are detailed in a paper... - December 19, 2008 - Anavex Life Sciences Corp.
AnaSpec Introduces Two New IRAK1 Antibodies – pThr 209 & 387
AnaSpec has introduced two new phosphospecific IRAK1 polyclonal antibodies – anti-IRAK1 (pThr 209) and anti-IRAK1 (pThr387). - December 18, 2008 - AnaSpec, EGT Group
Anavex Presents Potent Neuroprotective Effects of Anavex 1-41 at Neuroscience 2008
Anavex Life Sciences Corp., a biopharmaceutical company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, was selected to present its latest results with ANAVEX 1-41 at Neuroscience 2008, the 38th annual meeting of the Society... - December 17, 2008 - Anavex Life Sciences Corp.
Baxa Announces 2009 Course Dates for Its STAR Center® Training Facility
Baxa Corporation announces record number of course dates for its STAR Center in 2009. Together with the United States Pharmacopeia (USP), the company plans 22 class sessions focused on pharmacy best practice in relation to USP 797 regulatory compliance and hazardous drug handling. The STAR Center, a premier facility designed for cleanroom and pharmacy practice demonstration, is located at the company’s headquarters south of Denver, Colorado. - December 17, 2008 - Baxa Corporation
AnaSpec Introduces Industry’s First Fluorimetric Assay Kit for Aggrecanase-1 Activity Detection
AnaSpec has announced the release of the industry’s first fluorimetric assay optimized to detect ADAMTS-4 (aggrecanase-1) activity - the SensoLyteTM 520 Aggrecanase-1 Assay Kit. A FRET based assay, it is homogeneous and has an emission in the green range (Ex/Em= 490 nm/520 nm). The kit... - December 17, 2008 - AnaSpec, EGT Group
GeneThera Will Test Raw and Processed Milk for Johne’s Disease Due to Evidence Linking Johne’s Disease to Irritable Bowel Syndrome (IBS) and Chron’s Disease
GeneThera will test raw and processed milk for Johne’s disease due to evidence linking Johne’s disease to Irritable Bowel Syndrome (IBS) and Chron’s disease starting January, 2009. GeneThera, Inc. (GTHR.PK), GeneThera announces it will soon begin testing of raw and processed milk... - December 10, 2008 - GeneThera Inc.
Functional Genetics, Inc. Announces Agreement with Elanco, a Division of Eli Lilly and Company
Functional Genetics, Inc., a biotechnology research and development company, announced today that it has reached a collaborative research, license and commercialization agreement with Elanco, the animal health division of Eli Lilly and Company. The agreement establishes the framework for... - December 09, 2008 - Functional Genetics, Inc.
Baxa Features Rapid-Fill™ Colored Labels, PACT™ Products, Exacta-Mix™ 2400 Compounders and Abacus™ Software at the ASHP Mid-Year Clinical Meeting
Baxa Corporation announces its focus on new Rapid-Fill ASF colored label and Productivity and Compliance Tools (PACT) products at the 2008 American Society of Health-System Pharmacists Mid-year Clinical Meeting and Exhibition beginning today at the Orange County Convention Center in Orlando, FL. Also featured in Baxa booth #2249 are the Exacta-Mix™ 2400 Automated Compounder and Abacus™ TPN Calculation Software. - December 08, 2008 - Baxa Corporation
AnaSpec Signs Distribution Agreement with Yope Biotechnology
AnaSpec and Yope Biotechnology Co. Ltd. today announced a non-exclusive distributor agreement that will allow Yope Biotechnology Co. Ltd. to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted,... - December 04, 2008 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with Biogenuix Medsystems
AnaSpec and Biogenuix Medsystems Pvt. Ltd. today announced a non-exclusive distributor agreement that will allow Biogenuix Medsystems Pvt. Ltd. to distribute AnaSpec’s catalog and custom products throughout India. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted,... - November 28, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New Line of LL-37 GO™ Peptides
LL-37 peptides are AnaSpec’s latest addition to their expansive collection of research-ready, on-demand GO™ Peptides. - November 27, 2008 - AnaSpec, EGT Group
Accugenix Announces New CEO & President, Retains Former as R&D VP; Former COO Roger Nalepa Takes the Reins and Former CEO Doug Smith Refocuses on R&D
Accugenix, Inc. publicly announced today the promotion of former COO, Roger Nalepa, to the position of CEO & President, and the reassignment of former CEO Doug Smith to Vice President of Research & Development. Specializing in genetic microbial identification, the Delaware-based DNA... - November 27, 2008 - Accugenix, Inc.
Baxa Corporation Announces Co-Marketing Agreement with Industry Leaders Pharmacy OneSource, Inc, and ClinicalIQ, LLC
Announcing the collaboration of Baxa Corporation, ClinicalIQ LLC, and Pharmacy OneSource, Inc., bring greater understanding of, and compliance to, USP 797 for the healthcare industry. The alliance among these industry-leading companies provides health-system pharmacies with the tools to stay compliant with the standards set forth by USP. - November 24, 2008 - Baxa Corporation
Biotech Executive John Collar Named Executive Director of the Colorado BioScience Association, Effective December 8
Following an extensive national search, John Collar, Chief Operating Officer of Westminster-based Matrilinex, has been named Executive Director of the Colorado BioScience Association (CBSA), effective December 8, 2008. A seasoned senior executive, Collar has a background of solid corporate experience with a proven track record for strategic planning, managing to metrics, and c-level operational responsibilities. He succeeds Denise Brown, Founding Executive Director of CBSA, who retired Sept 30. - November 24, 2008 - Colorado BioScience Association
AnaSpec Releases 4 New Phosphospecific Anti-Tau Antibodies
AnaSpec is excited to announce the release of 4 more new phosphospecific anti-Tau antibodies. This represents the industry’s largest collection of anti-Tau antibodies - 17 phosphospecific and 9 non-phosphospecific antibodies. AnaSpec’s expertise in phosphopeptide synthesis combined... - November 23, 2008 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with Shanghai Universal Biotech Company
AnaSpec and Shanghai Universal Biotech Company today announced a non-exclusive distributor agreement that will allow Shanghai Universal Biotech Company to distribute AnaSpec’s catalog and custom products throughout China. - November 22, 2008 - AnaSpec, EGT Group
Nanion Increases Throughput and Cuts Costs with a New Industrial 96-Channel Patch Clamp Screening Robot
Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial ion channel drug screening and safety profiling, and with a price-per-data-point compatible with screening standards, the SyncroPatch 96 will offer the highest throughput in the market for high quality HTS-oriented ion channel screening. - November 20, 2008 - Nanion Technologies GmbH
Oberon FMR, Inc., Wins the Fourth Annual Dorsey & Whitney Venture Showcase Award, Presented at BioWest 2008
Oberon FMR, Inc., has won the fourth annual Dorsey & Whitney Venture Showcase Award at the 2008 BioWest Conference & Expo in Denver. The announcement is made by Christine Shapard, Interim Executive Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase award was provided by the Dorsey & Whitney law firm and announced at the Colorado Bioscience Association (CBSA) 2008 Awards Dinner. - November 19, 2008 - Colorado BioScience Association
AnaSpec Establishes New Dedicated GMP Manufacturing Facility
In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class... - November 16, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Series of Luminescent and Non-Luminescent Calcium Indicators
AnaSpec offers coelenterazine and several synthetic coelenterazine analogs for reconstituting aequorin in cells that have been transfected with apoaequorin cDNA. - November 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Improved AnaTagTM APC, B-PE and R-PE Labeling Kits
AnaSpec is pleased to announce the release of the improved AnaTagTM APC, B-PE and R-PE Labeling Kits. Labeling of antibodies can be both tedious and time-consuming. Without the use of proper techniques and reagents, the conjugation may result in suboptimal or no labeling. AnaSpec’s improved... - November 12, 2008 - AnaSpec, EGT Group
Baxa Expands Its Automated Syringe Processing Capabilities
Baxa Corporation is the first to provide colored labels for automated filling of sterile anesthesia syringes, with the addition of colored syringe labels to its Rapid-Fill™ Automated Syringe Filler offering. The system reduces pharmacy overhead for batching activities, while providing the opportunity for more adequate staff allocation and greater inventory control. - November 11, 2008 - Baxa Corporation
Colorado BioScience Association Honors the Best of Colorado’s Bioscience Industry
The Colorado BioScience Association (CBSA) has released winners of its 2008 Awards Program. Official presentation of the awards occurs Thursday, November 13, 6:30 to 8:30 p.m., at the CBSA’s annual awards dinner. Governor Bill Ritter, Jr., recipient of one of this year’s Chairman’s Awards, will serve as the Cooley Godward Kronish keynote speaker for this event as the Colorado Bioscience Association celebrates its fifth anniversary. - November 07, 2008 - Colorado BioScience Association
Endometriosis Patients Demand Awareness, Research, and Better Treatments: Sufferers Share What Works and What Does Not
In light of performers Julianne Hough’s and Lacey Schwimmer’s recent disclosure, Endometriosis patients around the world are coming together online to anonymously compare symptoms & related conditions with one another, share treatment reviews, and make research discoveries for future cures. - November 05, 2008 - CureTogether
AnaSpec Introduces Fluorescent Calcium Indicators
Calcium plays a vital role in the regulation of cardiac contractility, growth and gene expression; consequently, calcium measurement is critical in numerous biological investigations. Fluorescent probes that show spectral responses upon Ca2+ binding have enabled researchers to investigate changes... - November 05, 2008 - AnaSpec, EGT Group
National Speakers – Steven Burrill, Guy Kawasaki & T.R. Reid – and Expo with More Than 50 Bioscience Vendors To Attract 700+ at BioWest 2008, Nov. 13 & 14, in Denver
Outstanding national speakers Steven Burrill, Guy Kawasaki and T.R. Reid lead the conference lineup for BioWest 2008, plus 50+ bioscience vendors will introduce their products and services to more than 700 attendees. The BioWest Conference and Expo is the Rocky Mountain region’s preferred venue for visiting with researchers about their newest discoveries and meeting founders of the area’s most innovative and promising bioscience start-up companies. - November 01, 2008 - Colorado BioScience Association
Baxa Corporation Launches The Virtual Compounder™
Baxa Corporation announces the launch of The Virtual Compounder – interactive training capability that enhances the functionality of its CriticalPoint USP 797 Sterile Compounding Program. The Virtual Compounder is an innovative series of training lessons that allows users not only to read and memorize materials, but to demonstrate a clear understanding and proficiency in the concepts. - November 01, 2008 - Baxa Corporation
20+ Colorado Bioscience Companies Are Looking to Fill Positions at the 2008 BioWest Conference & Expo’s First Annual Job Fair
The Colorado BioScience Association (CBSA) is hosting a new Bioscience Job Fair the afternoon of November 14, 1:30 to 4 p.m., following the 2008 BioWest Grand Finale Luncheon. The BioWest Conference and Expo is the Rocky Mountain region’s preferred venue for visiting with researchers about their newest discoveries and meeting founders of the area’s most innovative and promising bioscience start-up companies. - October 30, 2008 - Colorado BioScience Association
Concierge MedTravel Bridges the Gap for Treatment of Prostate Cancer
Concierge MedTravel, website www.cmedtravel.com, a company bridging the gap for patients diagnosed with prostate cancer with highly advanced medical treatment called Ablatherm® HIFU currently not available in the United States, achieved an important milestone since the inception of Concierge... - October 24, 2008 - Concierge MedTravel
Patients Share Health Data, Become Researchers to Seek Cures for Their Conditions
CureTogether to Demonstrate at Health 2.0 Conference How Some Patients Are Responding to Inadequate Research by Doing It Themselves. - October 23, 2008 - CureTogether
IonSense to Present DART-ET Source for Mass Spectrometry at the Annual Symposium on Chemical and Pharmaceutical Structure Analysis
New technology enables high throughput direct analysis of solid and liquid samples for drug development, food safety, forensics, and medicinal chemistry. - October 23, 2008 - IonSense, Inc.
AnaSpec Introduces New PKD1 & PKD2 Antibodies
Protein kinase D (PKD belongs to the calcium calmodulin superfamily of kinases (2-3). - October 23, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyteTM MMP ELISA Kits
MMPs are key players in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, and cancer. - October 18, 2008 - AnaSpec, EGT Group
The 2008 BioWest Conference and Expo Announces National Speaker Lineup, New Job Fair and Popular Venture Showcase Competition
General registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2008. More than 700 participants are expected at this year’s event, November 13-14, at the Grand Hyatt in Denver. Noted author of The Art of the Start & business innovation expert Guy Kawasaki leads a prominent lineup of national presenters for BioWest 2008. - October 16, 2008 - Colorado BioScience Association
AnaSpec’s FRET Feature Article Available at Photonics.com
AnaSpec published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. - October 16, 2008 - AnaSpec, EGT Group
BellBrook Labs Announces a Kinase/ATPase Assay That is "2" Sensitive
The Transcreener ADP2 FP Assay is a homogenous fluorescence polarization assay that enables the facile detection and screening of established drug targets including protein and lipid kinases as wells as emerging targets such as heat shock proteins and other ATPases. - October 15, 2008 - BellBrook Labs
Finalists Selected for The BioWest 2008 Venture Showcase Competition
New therapeutic small molecule drugs; devices made of unique materials; a highly-sensitive biosensor; advanced DNA immunotherapies; high-protein, low-cost fish food; and, new materials for use in perio-plastic surgical procedures comprise the six finalists in this year’s BioWest Venture Showcase competition. The finalists were selected from a group of 22and will be presenting at the BioWest Venture Showcase on November 13 at the Grand Hyatt-Denver, 1750 Welton. - October 15, 2008 - Colorado BioScience Association
Baxa Corporation Features PadLock®Set Saver at the ANCC National Magnet Conference™
Baxa Corporation is promoting its new PadLock Set Saver at the ANCC National Magnet Conference, October 15-17, in Salt Lake City. An aseptic IV administration set storage solution, PadLock provides a secure seal for the end of the administration set, preventing contamination when the set is not... - October 15, 2008 - Baxa Corporation
Baxa Corporation’s UK Subsidiary Launches ZR® Pre-Filled Saline Flush Syringes
Baxa introduces new line of sterile, pre-filled saline syringes for safe and efficient flushing of IV lines. The ZR syringes meet NHS standards and promote best practice for catheter care. - October 14, 2008 - Baxa Corporation
AnaSpec Introduces Histone GO™ Peptides - Acetylated & Methylated
The core histones (H2A, H2B, H3 and H4) act as spools around which DNA winds. Covalent modification on the amino terminal of the core histones through de/acetylation, de/methylation and de/phosphorylation affect chromatin structure and exquisitely regulate gene expression.1-3 Histone... - October 11, 2008 - AnaSpec, EGT Group